+
Site Tour

Imaging debate: defending ICE J. Saw

13th Annual International Left Atrial Appendage Occlusion (LAAO) Summit - Imaging debate: defending ICE by Jacqueline Saw

Watch on Demand videos on LAAO Summit 2024

Related Videos

LAAO Summit - Imaging debate: Mini TEE

LAAO Summit - Device placement and DRT

LAAO Summit - Mastering leaks

LAAO Summit - The right antithrombotic regimen

LAAO Summit - TEE vs CT leaks

Review the Trends | Mitral focus

LAAO Summit - Sealing the appendage

SAFETY IS A JOURNEY | M. Swaans & G. Leurent

EACVI Summit 2023: Congress symposium

LAAO Summit 2023: LAAO therapies

ESC 2023 Tutorial – TriClip™ | Dr. Sanchis

LAAO Summit 2023: ICE

TRENDING TOPICS

AV Valves Summit 2024 | Opening of Day 2

AV Valves Summit 2024 | Opening of Day 2

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

AV Valves Summit 2024 | Closing of Day 1

AV Valves Summit 2024 | Closing of Day 1

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

Case Parade | Tricuspid focus

Case Parade | Tricuspid focus

M. Sitges, R. Estevez, V. Ninios, E. L. Heng, X. Freixa, W. Wojakowski, C. Besler

CONNEXT


TV
RELATED RESOURCES

Animation: Piccolo™

Amplatzer™ Amulet™ LAA Occluder

Case Parade | Mitral focus

LAAO Summit - New data & future trials

CONNEXT


HUB
RELATED RESOURCES

Monitoring for AF prior to PFO closure

Clinical insights: LAAO

Amulet IDE Results

Clinical insights: Intaglio™

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline